Multiple Myeloma Pipeline & Clinical Trials Market Report

added blog Other

2026-02-13 08:49:02 -

According to FutureWise analysis the market for multiple myeloma in 2026 is US$ 27.56 billion, and is expected to reach US$ 46.18 billion by 2036 at a CAGR of 5.30%. Market growth is driven by the rising global incidence of hematologic cancers and the adoption of advanced therapies like proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and CAR-T cell therapies. Continuous...

0 Comments 0 Shares 430 Views 0 Reviews